Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: June 24, 2022 Report Code: GDME1390EPD-ST

Select Item

Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective. They are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon.

The topical absorbable hemostats market research report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities. The report also reviews the major players involved in the development of topical absorbable hemostats and lists all their pipeline projects.

Which are the key territories in the topical absorbable hemostats pipeline market?

The key territories in the topical absorbable hemostats pipeline market are the United States, Europe, India, South Korea, China, Japan, Canada, Russia, Singapore, Taiwan, the United Kingdom, Vietnam, Australia, and Philippines. The United States has the highest number of pipeline products.

Topical absorbable hemostats pipeline market, by territories

Topical absorbable hemostats pipeline market, by territories

For more territory insights, download a free report sample

Which are the key categories in the topical absorbable hemostats pipeline market?

The key categories in the topical absorbable hemostats pipeline market are Collagen Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Thrombin Based Hemostats, Polysaccharide Based Hemostats, Combination Hemostats – Pads, and Gelatin Based Hemostats. Collagen Based Hemostats has the highest number of pipeline products.

Topical absorbable hemostats pipeline market, by categories

Topical absorbable hemostats pipeline market, by categories

For more category insights, download a free report sample

Which are the key regulatory paths in the topical absorbable hemostats pipeline market?

The key regulatory paths in the topical absorbable hemostats pipeline market are 510(k), CE, PMA, ICAC, NMPA, MDITAC, MDL, NIFDS, Ninsho, HSA, BOPA, Shonin, TGA, and UKCA. 510(k) has the highest number of pipeline products.

Topical absorbable hemostats pipeline market, by companies

Topical absorbable hemostats pipeline market, by companies

For more regulatory path insights, download a free report sample

Which are the key companies in the topical absorbable hemostats pipeline market?

The key companies in the topical absorbable hemostats pipeline market are 3-D Matrix Ltd, Acro Biomedical Co Ltd, Advanced Biotech Products Pvt Ltd, Angiotech Pharmaceuticals Inc, Anika Therapeutics Inc, APRUS Bio-Medical Innovations Pvt Ltd, Arch Therapeutics Inc, Baxter Healthcare Corp, Beth Israel Deaconess Medical Center, Biomedica Management Corp, Biom’Up SAS, and Cellphire Inc.

Market report overview

Key territories The United States, Europe, India, South Korea, China, Japan, Canada, Russia, Singapore, Taiwan, the United Kingdom, Vietnam, Australia, and Philippines
Key categories Collagen Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Thrombin Based Hemostats, Polysaccharide Based Hemostats, Combination Hemostats – Pads, and Gelatin Based Hemostats
Key regulatory paths 510(k), CE, PMA, ICAC, NMPA, MDITAC, MDL, NIFDS, Ninsho, HSA, BOPA, Shonin, TGA, and UKCA
Key companies 3-D Matrix Ltd, Acro Biomedical Co Ltd, Advanced Biotech Products Pvt Ltd, Angiotech Pharmaceuticals Inc, Anika Therapeutics Inc, APRUS Bio-Medical Innovations Pvt Ltd, Arch Therapeutics Inc, Baxter Healthcare Corp, Beth Israel Deaconess Medical Center, Biomedica Management Corp, Biom’Up SAS, and Cellphire Inc

Scope

  • Extensive coverage of the Topical Absorbable Hemostats under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

  • Identify and understand important and diverse types of Topical Absorbable Hemostats under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

3-D Matrix Ltd
Advamedica Inc
Angiotech Pharmaceuticals Inc
Anika Therapeutics Inc
APRUS Bio-Medical Innovations Pvt Ltd
Arch Therapeutics Inc
Baxter Healthcare Corp
Beth Israel Deaconess Medical Center
Biomedica Management Corp
Biom'Up SAS
Cellphire Inc
Ceramicos Para Aplicacoes Medicas SA
Columbia University
Covalent Medical, Inc. (Inactive)
Covalon Technologies Ltd
CR Bard Inc
Cresilon Inc
Endomedix Incorporated
Entegrion Inc
Ethicon US LLC
ETX Pharma Inc
Gamma Therapeutics Inc
GATT Technologies BV
Haemostatix Ltd
Hemostasis LLC
HLL Lifecare Ltd
Ichor Sciences LLC
Keratin Biosciences Inc
Leader Biomedical Europe BV
Medcura Inc
Protege Biomedical LLC
Resorba GmbH
Rice University
Sanofi Biosurgery Inc
Sea Run Holdings Inc
St Teresa Medical Inc
STB Lifesaving Technologies
Tectum
The Medicines Co
Therus Corporation
Thrombotargets Corp
United Health Products, Inc.
University of Grenoble Alpes
Virginia Commonwealth University
Xcede Technologies Inc
Z-Medica LLC

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 12

2 Introduction 13

2.1 Topical Absorbable Hemostats Overview 13

3 Products under Development 14

3.1 Topical Absorbable Hemostats – Pipeline Products by Stage of Development 14

3.2 Topical Absorbable Hemostats – Pipeline Products by Segment 15

3.3 Topical Absorbable Hemostats – Pipeline Products by Territory 16

3.4 Topical Absorbable Hemostats – Pipeline Products by Regulatory Path 17

3.5 Topical Absorbable Hemostats – Pipeline Products by Estimated Approval Date 18

3.6 Topical Absorbable Hemostats – Ongoing Clinical Trials 19

4 Topical Absorbable Hemostats – Pipeline Products under Development by Companies 20

4.1 Topical Absorbable Hemostats Companies – Pipeline Products by Stage of Development 20

4.2 Topical Absorbable Hemostats – Pipeline Products by Stage of Development 22

5 Topical Absorbable Hemostats Companies and Product Overview 24

5.1 3-D Matrix Ltd Company Overview 24

5.1.1 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.2 Acro Biomedical Co Ltd Company Overview 30

5.2.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.3 Advanced Biotech Products Pvt Ltd Company Overview 31

5.3.1 Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.4 Angiotech Pharmaceuticals Inc Company Overview 32

5.4.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.5 Anika Therapeutics Inc Company Overview 33

5.5.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.6 APRUS Bio-Medical Innovations Pvt Ltd Company Overview 34

5.6.1 APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.7 Arch Therapeutics Inc Company Overview 35

5.7.1 Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.8 Baxter Healthcare Corp Company Overview 39

5.8.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 39

5.9 Beth Israel Deaconess Medical Center Company Overview 41

5.9.1 Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview 41

5.10 Biomedica Management Corp Company Overview 42

5.10.1 Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 42

5.11 Biom’Up SAS Company Overview 45

5.11.1 Biom’Up SAS Pipeline Products & Ongoing Clinical Trials Overview 45

5.12 Cellphire Inc Company Overview 47

5.12.1 Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.13 Ceramicos Para Aplicacoes Medicas SA Company Overview 51

5.13.1 Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview 51

5.14 Columbia University Company Overview 52

5.14.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 52

5.15 Covalent Medical, Inc. (Inactive) Company Overview 53

5.15.1 Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53

5.16 Covalon Technologies Ltd Company Overview 54

5.16.1 Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.17 CR Bard Inc Company Overview 56

5.17.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.18 Cresilon Inc Company Overview 58

5.18.1 Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.19 Endomedix Incorporated Company Overview 60

5.19.1 Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview 60

5.20 Entegrion Inc Company Overview 62

5.20.1 Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.21 Ethicon US LLC Company Overview 63

5.21.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 63

5.22 ETX Pharma Inc Company Overview 65

5.22.1 ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.23 Gamma Diagnostics Inc Company Overview 66

5.23.1 Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.24 GATT Technologies BV Company Overview 67

5.24.1 GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview 67

5.25 Haemostatix Ltd Company Overview 69

5.25.1 Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

5.26 Hemostasis LLC Company Overview 71

5.26.1 Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 71

5.27 HLL Lifecare Ltd Company Overview 75

5.27.1 HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

5.28 Ichor Sciences LLC Company Overview 76

5.28.1 Ichor Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.29 Keratin Biosciences Inc Company Overview 77

5.29.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.30 Leader Biomedical Europe BV Company Overview 78

5.30.1 Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview 78

5.31 Medcura Inc Company Overview 79

5.31.1 Medcura Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.32 Protege Biomedical LLC Company Overview 82

5.32.1 Protege Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 82

5.33 Resorba GmbH Company Overview 83

5.33.1 Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 83

5.34 Rice University Company Overview 85

5.34.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 85

5.35 Sanofi Biosurgery Inc Company Overview 86

5.35.1 Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.36 Sea Run Holdings Inc Company Overview 88

5.36.1 Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.37 St Teresa Medical Inc Company Overview 89

5.37.1 St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.38 STB Lifesaving Technologies Company Overview 91

5.38.1 STB Lifesaving Technologies Pipeline Products & Ongoing Clinical Trials Overview 91

5.39 Tectum Company Overview 92

5.39.1 Tectum Pipeline Products & Ongoing Clinical Trials Overview 92

5.40 The Medicines Co Company Overview 94

5.40.1 The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview 94

5.41 Therus Corporation Company Overview 95

5.41.1 Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview 95

5.42 Thrombotargets Corp Company Overview 96

5.42.1 Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview 96

5.43 United Health Products, Inc. Company Overview 100

5.43.1 United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100

5.44 University of Grenoble Alpes Company Overview 105

5.44.1 University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview 105

5.45 Virginia Commonwealth University Company Overview 106

5.45.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 106

5.46 Xcede Technologies Inc Company Overview 107

5.46.1 Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.47 Z-Medica LLC Company Overview 111

5.47.1 Z-Medica LLC Pipeline Products & Ongoing Clinical Trials Overview 111

6 Topical Absorbable Hemostats- Recent Developments 114

6.1 Jun 10, 2022: Anika to Participate in the Sidoti Small Cap Virtual Investor Conference 114

6.2 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors 114

6.3 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 114

6.4 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 114

6.5 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference 114

6.6 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share 115

6.7 May 13, 2022: Cadila Pharma appoints Jawed Zia as CEO 115

6.8 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference 115

6.9 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company 115

6.10 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix 116

6.11 May 10, 2022: Baxter to Host 2022 Investor Conference 116

6.12 May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022 116

6.13 May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results 116

6.14 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022 120

6.15 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference 120

6.16 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022 120

6.17 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results 122

6.18 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition 122

6.19 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference 122

6.20 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results 122

6.21 Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022 124

6.22 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference 124

6.23 Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference 124

6.24 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results 124

6.25 Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference 125

6.26 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022 125

6.27 Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results 125

6.28 Feb 22, 2022: Sanara MedTech Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021 127

6.29 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors 127

6.30 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference 128

6.31 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference 128

6.32 Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022 128

6.33 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference 128

6.34 Jan 27, 2022: Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference 129

6.35 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results 129

6.36 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors 130

6.37 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 130

6.38 Jan 04, 2022: Arch Therapeutics Announces Appointment of Guy Fish to the Board 130

6.39 Dec 22, 2021: Sanara MedTech Announces the Retirement of J. Michael Carmena and Appointment of Eric Tanzberger to its Board of Directors 131

6.40 Dec 22, 2021: United Health Products provides regulatory status update 131

6.41 Dec 15, 2021: Sanara MedTech Announces the Appointment of Roszell Mack III to its Board of Directors 131

6.42 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021 132

6.43 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results 133

6.44 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference 134

6.45 Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE 134

6.46 Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences 134

6.47 Nov 08, 2021: IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan’s High-Quality, Integrated Medical Services to the World 135

6.48 Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results 135

6.49 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference 138

6.50 Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors 138

6.51 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER 139

6.52 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021 149

6.53 Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021 150

6.54 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference 150

6.55 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021 150

6.56 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations 152

6.57 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference 152

6.58 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021 152

6.59 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors 153

6.60 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors 153

6.61 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 153

6.62 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021 154

6.63 Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference 154

6.64 Aug 30, 2021: Covalon Announces Fiscal 2021 Q3 Results 154

6.65 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 155

6.66 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference 158

6.67 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference 158

6.68 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results 158

6.69 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021 160

6.70 Jul 29, 2021: Baxter to Present at UBS Genomics

2.0 and MedTech Innovations Summit 161

6.71 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results 161

6.72 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference 162

6.73 Jul 27, 2021: Stryker reports second quarter 2021 operating results 162

6.74 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results 163

6.75 Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021 164

6.76 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results 164

6.77 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 165

6.78 Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update 165

6.79 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer 166

7 Appendix 167

7.1 Methodology 167

7.2 About GlobalData 169

7.3 Contact Us 170

7.4 Disclaimer 170

Frequently asked questions

Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Wound Care Management reports
Medical Devices
New
Clinical Chemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | November 2023
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | November 2023
Medical Devices
United States Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | December 2021
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more